PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Loss of function mutations of Perk (eukaryotic translation initiation factor 2 alpha kinase 3) in humans and mice cause severe neonatal developmental defects, including diabetes, growth retardation and multiple skeletal dysplasias. Comprehensive analyses on bone tissue, at the cellular and molecular level in PERK‐deficient mice demonstrated that neonatal Perk−/− mice are severely osteopenic, which is caused by a deficiency in the number of mature osteoblasts, impaired osteoblast differentiation, and reduced type I collagen secretion. Impaired differentiation of osteoblasts in Perk KO mice was associated with decreased expression of Runx2 and Osterix, key regulators of osteoblast development. Reduced cell proliferation and reduced expression of key cell cycle factors including cyclin D, cyclin E, cyclin A, Cdc2, and CDK2 occur in parallel with the differentiation defect in mutant osteoblasts. In addition, the trafficking and secretion of type I collagen is compromised as manifested by abnormal retention of procollagen I in the endoplasmic reticulum, and reduced mature collagen production and mineralization. Taken together, these studies identify PERK as a novel regulator of skeletal development and osteoblast biology. J. Cell. Physiol. 217: 693–707, 2008. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608 · cited 2×
“The parameters measured were based on the internationally accepted standard for the presentation of histomorphometric data (Parfitt et al., 1987).”
MethodProtein translation and folding are coupled by an endoplasmic-reticulum-resident kinase
Harding, H. P., Zhang, Y., & Ron, D. (1999) · Nature · doi:10.1038/16729 · Cited by 3,310 · cited 1×
“Under conditions of acute ER stress in vitro, ATF4 is translationally up-regulated via PERK dependent phosphorylation of eIF2a and is claimed to be major downstream target of PERK regulation (Harding et al., 2000).”
BackgroundDelépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813 · cited 1×
“…recessive disorder that is characterized by the early onset of type I 694 W E I E T A L . diabetes, growth retardation and multiple skeletal dysphasia, including epiphyseal dysplasia, bone fractures and later osteoporosis (Delepine et al., 2000; Biason-Lauber et al., 2002; Brickwood et al., 2003).”
BackgroundForlino, A., Tani, C., Rossi, A., Lupi, A., Campari, E., Gualeni, B., Bianchi, L., Armini, A., Cetta, G., Bini, L., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200600919 · Cited by 54 · cited 1×
“Activation of UPR had been found in osteoblasts from some OI patients and oim mice (Lamande et al., 1995; Forlino et al., 2007).”
Background
Cited by
Luo, B., & Lee, A. S. (2013) · Oncogene · doi:10.1038/onc.2012.130 · Cited by 560
Pharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 520
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3109 · Cited by 443
“Our results are consistent with endoplasmic reticulum stress independent role of PERK in tumor physiology, as shown for beta cell proliferation, pancreatic exocrine cell viability, and proliferation and differentiation of osteoblasts (13, 14, 20).”
BackgroundResultKaragöz, G. E., Acosta-Alvear, D., & Walter, P. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033886 · Cited by 310
PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
Bobrovnikova-Marjon, E., Grigoriadou, C., Pytel, D., Zhang, F., Ye, J., Koumenis, C., Cavener, D., & Diehl, J. A. (2010) · Oncogene · doi:10.1038/onc.2010.153 · Cited by 300
Self-citation
Metadata
- Authors
- Wei, J., Sheng, X., Feng, D., McGrath, B., & Cavener, D. R.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2008-08-06
- Volume
- 217
- Issue
- 3
- Pages
- 693-707
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1983738559
- Cited by
- 127
- References
- 5
- FWCI
- 2.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. https://app.cochat.ai/papers/10.1002/jcp.21543
- The paper
- Wei, J., Sheng, X., Feng, D., McGrath, B., & Cavener, D. R. (2008). PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.21543
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.